The #AIEye: Cisco (NasdaqGS: $CSCO) Partners with Oxbotica for Autonomous Vehicle Solutions, IBM (NYSE: $IBM) Announces Strategic Alliance with C3.ai for #AI Digital Transformation, Accenture (NYSE: $ACN) Acquires Mudano

The #AIEye: Cisco (NasdaqGS: $CSCO) Partners with Oxbotica for Autonomous Vehicle Solutions, IBM (NYSE: $IBM) Announces Strategic Alliance with C3.ai for #AI Digital Transformation, Accenture (NYSE: $ACN) Acquires Mudano

Global AI #Cybersecurity Market to Reach $38.2 Billion by 2026

Point Roberts WA, Vancouver BC – February 28, 2020  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2020/022820-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2020/artificial-intelligence/02281AIEye-CSCO-IBM.asp

Hear the Ai Eye on Spotify  

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:CSCO) (NYSE:IBM) (NYSE:ACN)

Autonomous vehicle software firm Oxbotica and Cisco Systems, Inc. (NasdaqGS:CSCO) have partnered to solve the large data transfer challenge for autonomous vehicle fleets. They plan to do this through the OpenRoaming platform, a “a Cisco-initiated federation of providers utilising standards-based wireless technology.” Ozgur Tohumcu, CEO at Oxbotica, said:

"As part of our Universal Autonomy vision, our pioneering software already reduces the amount of data sharing that is required, allowing vehicles to operate wherever they are, with or without network connection. In fact, our software has been designed to operate not dependent on any infrastructure, so it can understand the vehicle's environment in infinite detail. However, we fully recognise that in an autonomous world, fleets will need to upload and download vast amounts of data and the partnership with Cisco offers us the chance to solve one of the greatest data challenges of the future, already today."

IBM (NYSE:IBM) has announced a global strategic alliance with leading enterprise AI software provider C3.ai for digital transformation with AI. This will involve the joint development, marketing, selling and deployment of AI applications supported by the C3 AI Suite and IBM Services. Jesus Mantas, Managing Partner, IBM Global Business Services, explained:

"Businesses need to move beyond experimenting with limited-impact AI applications, constrained by quality and availability of data, and implement industrial strength, scaled deployments of mission critical AI applications that deliver impact at scale in months, not years. The combination of C3.ai, IBM Services, and IBM Watson can help businesses rapidly embed AI into their critical workflows, enabling our clients to move to the future at pace."

Accenture (NYSE:ACN) has completed the acquisition of Mudano, a “strategic data consultancy to U.K. financial services firms,” which leverages machine learning and AI research. The Mudano team will join Accenture’s Applied Intelligence, described as the latter’s “approach to scaling AI for our clients.” An excerpt from the press release provides an outline of Applied Intelligence:

We embed AI-powered data, analytics and automation capabilities into business workflows to accelerate time to value. Our expertise in defining end-to-end strategy, combined with deep data infrastructure capabilities, cognitive services and industrialized accelerators help smooth clients’ path to AI adoption, extending human capabilities and supporting clients in scaling AI responsibly. Recognized as a leader by industry analysts, we collaborate with a powerful global alliance, innovation and delivery network to help clients deploy and scale AI within any market and industry.

Global AI Cybersecurity Market to Reach $38.2 Billion by 2026

Research published from ReportsnReports finds that the global AI in Cybersecurity market will grow from $8.8 billion in 2019 to $38.2 billion by 2026 with a compound annual growth rate (CAGR) of 23.3 percent. An excerpt from the report description outlines the market drivers:

Major drivers for the market’s growth are growing adoption of IoT and increasing number of connected devices, rising instances of cyber threat, growing concerns of data protection, and increasing vulnerability of Wi-Fi networks to security threats. Furthermore, underlying opportunities for the AI in cybersecurity market include growing need for cloud-based security solutions among SMEs and increased use of social media for business functions. Major restraints for the market are the inability of AI to stop zero-day and advanced threats, and rise in insider cyber threats. Limited number of cybersecurity and AI professionals, and lack of interoperability with existing information systems pose major challenges to the AI in cybersecurity market.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI  Eye

For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

Contact Investorideas.com

800 665 0411

  

Get more tech stocks investor ideas- news, articles, podcasts  and stock directories

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (OTCQB: $PBIO), (TSX: $TRST.TO) (NYSE: $CTST) (TSXV: $NDVA.V) (TSXV: $JWCA.V)

Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (OTCQB: $PBIO), (TSX: $TRST.TO) (NYSE: $CTST) (TSXV: $NDVA.V) (TSXV: $JWCA.V)

Delta, Kelowna, BC, February 28, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/022820-StocksToWatch.mp3

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/02281PBIO-TRST-CTST-NDVA-JWCA.asp

Hear Investor ideas cannabis potcast on iTunes  

Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few public announcements.

Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, announced the official opening of its new Ultra Shear Technology™ ("UST™") Demonstration Laboratory.  The UST Demo Lab is located in the Company's South Easton, Massachusetts facility.

A major purpose of the UST Demo Lab is to showcase the ability of the Company's revolutionary UST Platform to process CBD oil into true, high quality, water-soluble nanoemulsions. It is expected that nanoemulsions of CBD will be more stable, have superior aesthetic quality, and offer higher bioavailability than the standard macro/microemulsions used in most CBD products today (Nanoemulsions, in Handbook of Nanomaterials in Industrial Applications, Ghodake and Patravale, 2018).  A second purpose is to invite potential purchasers of the Company's UST-based BaroShear Systems (initial release expected Q4 2020) to evaluate how their CBD and other product formulations work with the Company's revolutionary UST platform.

This Company today released a new short video demonstrating how CBD oil from an independent manufacturer was processed into a clear, water-soluble nanoemulsion using a UST-based, first generation BaroShear system. The video shows the CBD oil and water mixture prior to and after UST processing.

Link to new short video showcasing the UST Demonstration Lab: PBI UST CBD Video

Kenneth F. Micciche, Director of PBI's UST Program, said: "We processed samples of CBD oil formulations from several highly interested companies over the past two months, in an effort to optimize the service we announced today.  The results speak for themselves: one group (Vegas CBD Factory) ordered six BaroShear K45 systems (for Q4 2020 delivery and installation).  We believe several more companies who participated in the early evaluation process are close to giving us their purchase orders.  The ability to showcase the UST platform in real life, and see the final product first-hand, has been shown to be vital to our marketing efforts.  As has been said in the past: 'build it and they will come'. The opening of the UST Demo Lab is a critical accomplishment in our UST sales and marketing strategy."

Richard T. Schumacher, President and CEO of PBI commented: "The initial reactions from manufacturers of topical and ingestible cannabidiol products processed in our lab during the trial period have been extremely positive. They quickly saw how they could realize substantial cost reductions while eliminating the overloading of poorly water-soluble CBD and other cannabinoids into products to achieve targeted dosing levels. We believe our breakthrough technology platform provides them with a new-found ability to provide safe and effective dosing for their customers, which in turn should stimulate greater growth in the market for CBD-based products overall, and strong sales of our BaroShear product line when it is released to the market later this year."

CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST) announced that on February 27, 2020 the Company received written notification from the New York Stock Exchange that CannTrust is no longer in compliance with the NYSE's continued listing standard rules because the per share trading price of the Company's common shares has fallen below the NYSE's share price rule.  The NYSE requires the average closing price of a listed company's common shares to be at least US $1.00 per share over a consecutive 30 trading-day period. As of February 25, 2020, the 30 trading-day average closing price of the Company's common shares was US $0.99.

In accordance with the NYSE's rules, CannTrust has six months from the receipt of the notice to regain compliance. During this time period, the Company's common shares will continue to be listed and trade on the NYSE as usual.

Under NYSE rules, CannTrust can regain compliance at any time during the six-month period if its common shares have a closing price of at least US $1.00 on the last trading day of any calendar month during the period and also have an average closing price of at least US $1.00 over the 30 trading-day period ending on the last trading day of that month or on the last day of the cure period.

Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF) and Lift & Co. Corp. (TSXV:LIFT) (OTCQB:LFCOF) announced the release of Indiva’s CannSell branded education module. The CannSell certification program, created by Lift & Co., in exclusive partnership with MADD Canada, is currently utilized in eight Canadian jurisdictions. CannSell also serves as the provincially-mandated training program for all cannabis retail workers in Ontario. These frontline staff members are responsible for educating consumers on the safe use of cannabis where it is sold. The Indiva education experience on the CannSell platform offers an overview of the Company, its product portfolio, and its commitment to quality, innovation and sustainability.

“We are proud to partner with Lift & Co. in educating this important community about Indiva and our products,” Niel Marotta, Indiva’s President and Chief Executive Officer, said. “Many consumers do not know what to purchase prior to entering a store. Budtenders are a great first point of contact for those interested in learning more about cannabis. Their guidance makes cannabis more accessible and helps Canadians make informed decisions. We look forward to staying connected to the budtender community and working in partnership with organizations like Lift & Co. to educate the public about cannabis, cannabis products and responsible use.”

“Through the CannSell platform, Lift & Co. is able to support brands like Indiva to deliver brand education directly to Canadian budtenders who are critical to consumers’ cannabis education and eventual purchase decisions,” Matei Olaru, CEO of Lift & Co., said. “Whether it’s through this platform, lift.co or Cohesion, Lift & Co.’s entire platform connects brands like Indiva to consumers through several key touchpoints.”

James E. Wagner Cultivation Corporation (TSXV: JWCA.V) (OTCQX: JWCAF) announced that it has entered into a Memorandum of Understanding with CannNext BV, a company based in Amsterdam, the Netherlands, pursuant to which JWC will assist CannNext with its tender to the Government of the Netherlands for a licence to produce medical cannabis in the Netherlands.

In support of CannNext’s Tender, JWC has provided certain necessary commitments and attestations required by the Government of the Netherlands. In addition, in connection with the Tender process and, if the Tender is successful, the resulting anticipated production of medical cannabis in the Netherlands, JWC will provide CannNext with industry knowledge and experience related to the cultivation and production of medical cannabis for a consumer market.

The MOU outlines the parties’ intention to collaborate in developing cannabis cultivation best-practices. This will involve research and development related to strains, grow methods and lighting practices. JWC and CannNext also intend to negotiate a definitive agreement pursuant to which CannNext will agree to represent JWC in the Netherlands and the European Union for licensing of JWC’s GrowthSTORM™ technology. JWC will also acquire a minority equity position in CannNext.

CannNext is  focused on the research and development related to improving yields for controlled medical cannabis cultivation both for and with its own clients. CannNext’s state-of-the-art government licensed, research facility is also located in the Netherlands, and can be immediately converted to production.

“We believe that shaping alliances with companies that focus on high-end medical cannabis will benefit both parties to realize a global reach and leverage combined knowledge”, says Eric Uleman, managing director of CannNext. “Combining the long-standing cultivation knowledge of JWC and our focus on light and grow strategies, will result in increasing our chances of becoming a winner in the Dutch tender. We visited the JWC site at 530 Manitou Drive, Kitchener, Ontario, and found that it aligns with our view of how a best-in-class indoor facility would look. JWC delivers the best medical product for patients driven by personal passion and its advanced cultivation technology.”

“Our proprietary GrowthSTORM™ technology is the foundation for our success here in Canada,” says Nathan Woodworth, CEO and President of JWC. We believe by sharing our technology and knowledge with CannNext, we will establish an important gateway to the European Union Market. The Netherlands has reputation for being a frontrunner in medical cannabis and represents one of the largest recreational markets in the world.”

Investor ideas reminds all listeners to read our disclaimers and disclosures on the

Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info:

https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android  

Contact Investorideas.com

800-665-0411

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

#CryptoCorner: LINE (NYSE: $LN) Changes #Crypto Exchange from Singapore-Based BITBOX to US Platform, Grayscale (OTC: $GDLCF) and Tradeblock Launch DLCX, KLM Royal Dutch Airlines (OTC: $KLMR) Leveraging #Blockchain for Financial Settlements

#CryptoCorner: LINE (NYSE: $LN) Changes #Crypto Exchange from Singapore-Based BITBOX to US Platform, Grayscale (OTC: $GDLCF)  and Tradeblock Launch DLCX, KLM Royal Dutch Airlines (OTC: $KLMR) Leveraging #Blockchain for Financial Settlements

Point Roberts, WA, Delta BC February 28, 2020 -  Investorideas.com, a leader in crypto and blockchain investing news brings you today’s edition of the Crypto Corner podcast and commentary on what’s driving the cryptocurrency market .

Listen to today’s Crypto Corner Podcast:  

https://www.investorideas.com/Audio/Podcasts/2020/022820-CryptoMarket.mp3

Read this in full at https://www.investorideas.com/news/2020/crypto-corner/02281LN-GDLCF.asp

Get the Crypto Corner Podcast on iTunes

Stocks discussed: (NYSE:LN) (OTC:GDLCF) (OTC:KLMR)

When we left off on Wednesday’s Crypto Corner, Bitcoin (BTC), was trading for about $9,050. Since then it has continued to fall, reaching a depth of around $8,500 earlier today, before rebounding slightly to a trading price of $8,685 at press time, according to data from CoinMarketCap. This decline in Bitcoin, and by extension the wider crypto market of which it comprises 64 percent, coincides with an analogous drop in the stock market, where the Dow saw its largest point drop in history just yesterday. This is largely attributed to growing global concerns over the Coronavirus outbreak.

Japanese messaging firm LINE Corporation (NYSE:LN), has announced that it is closing its Singapore-based crypto exchange BITBOX, in favour of a U.S.-based platform called BITFRONT. An excerpt from its welcome announcement reads:

BITFRONT, formerly known as BITBOX, has been redesigned to provide a more sophisticated digital currency exchange service.

BITFRONT aims to provide the most secure and reliable digital currency trading environment for new and experienced traders around the globe to trade freely.

The announcement indicates that users in the U.S. who live “in eligible states can deposit USD to trade cryptocurrency by linking their bank account to BITFRONT” “via Automatic Clearing House (ACH) or wire transfer.”

Indices provider TradeBlock and Grayscale Investments, manager of Grayscale Digital Large Cap Fund (OTC:GDLCF), have announced the launch of the TradeBlock Grayscale Digital Large Cap Index (DLCX). The DLCX will provide “market participants increased visibility into the daily performance and composition of GDLCF.” According to the press release, “GDLCF’s portfolio construction methodology was developed and is managed by Grayscale, an intra-day index price will now be calculated, verified, and published in real-time by TradeBlock, an independent pricing source.”

KLM Royal Dutch Airlines (OTC:KLMR), in collaboration with software services provider unchain.io and enterprise software firm R3, is leveraging blockchain technology to simplify financial processes. Taking the form of an intercompany settlement application, the goal of the collaboration is to “to simplify the accounting process in a secure and efficient manner.” Jelle van der Ploeg, CTO at unchain.io said:

“Unchain’s mission is to provide organizations with solutions to simplify sharing data and transacting with their value chain. In the case of KLM, this means digitally transforming the settlement process with its subsidiaries. We’re extremely proud to work with KLM and R3 on this innovative project and look forward to further expanding the solution, offering value to KLM and its partners.”

Sam Mowers, Investorideas

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Crypto Corner is part of the Investor Ideas Membership content

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Cryptocurrency Disclaimer

Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.

Copyright and ownership: Crypto Corner is an Investorideas.com content brand

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

Contact Investorideas.com

800-665-0411

Get more Bitcoin and Blockchain Investor ideas  – news, articles, podcasts and stock directories 

#Coronavirus #COVID19 stocks section added to Biotech stocks directory

#Coronavirus #COVID19 stocks section added to Biotech stocks directory

New Crypto and Biotech Stocks added to Investor Ideas

Nasdaq/Nyse IPO’s in Biotech, Luxury Retail, Real Estate, Sports, Restaurants and China-Asia

Point Roberts WA, Delta BC, February 28, 2020 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories in biotech, retail, real estate, sports, food & beverage (restaurants), China-Asia and crypto.

Read this in full at https://www.investorideas.com/news/2020/main/02281Stocks.asp

This week’s new companies includes many Nasdaq/NYSE IPO’s in biotech and life sciences, retail, real estate, sports (boating), food and beverage (restaurants) and a new China-Asia IPO involved in insurance products and services or customers in China.

Also new this week is the TSX Venture listed crypto company, Bitfarms Ltd. (TSXV:BITF.V) and biotech companies – including some who are working on Coronavirus solutions.

Be sure to check out the updated Biotech Stocks Directory which now includes stocks involved in combating Coronavirus (COVID19) – according to company news and commentary.  https://www.investorideas.com/BIS/stock_list.asp

New stocks added to biotech stocks directory

Evelo Biosciences, Inc. (Nasdaq:EVLO) is a clinical stage biotechnology company developing oral biologics that act on SINTAX with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic and neurological systems. The company’s first product candidates are monoclonal microbials, single strains of microbes selected for defined pharmacological properties. Evelo’s therapies have the potential to be effective, safe and affordable medicines to improve the lives of people with chronic diseases and cancer. Evelo currently has four product candidates: EDP1815, EDP1867, and EDP2939 for the treatment of inflammatory diseases, and EDP1503 for the treatment of cancer. Evelo is also advancing additional oral biologics through preclinical development in other disease areas.

Vaxart (NasdaqGS: VXRT) is a clinical-stage biotechnology company focused on developing oral recombinant protein vaccines based on its proprietary oral vaccine platform. Vaxart’s vaccines are designed to generate broad and durable immune responses that protect against a wide range of infectious diseases and may also be useful for the treatment of chronic viral infections and cancer. Vaxart’s vaccines are administered using a convenient room temperature-stable tablet, rather than by injection. Vaxart believes that tablet vaccines are easier to distribute and administer than injectable vaccines and have the potential to significantly increase vaccination rates. Vaxart’s development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV).

Cocrystal Pharma, Inc. (NasdaqCM: COCP) is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, noroviruses and coronaviruses.

Enlivex Therapeutics Ltd. (NasdaqCM:ENLV) is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve an out of control immune system (e.g. Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.

Beyond Air, Inc. (NasdaqCM:XAIR) is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System, LungFit™ that uses NO generated from ambient air to deliver precise amounts of NO to the lungs for the potential treatment of a variety of pulmonary diseases. The LungFit™ can generate up to 400 ppm of NO for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose. The Company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for lower respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary LungFit™ in clinical trials for the treatment of bronchiolitis and severe lung infections such as nontuberculous mycobacteria (NTM).

New Frontier Health Corporation (NYSE:NFH) is the operator of United Family Healthcare (UFH), a leading private healthcare provider offering comprehensive premium healthcare services in China through a network of private hospitals and affiliated ambulatory clinics. UFH currently has nine hospitals and in total in operation or under construction in all four 1st tier cities and selected 2nd tier cities.

Trxade Group, Inc. (NasdaqCM:MEDS) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; the Trxade B2B trading platform with 11,900 registered pharmacies, licensed virtual Wholesale and Mail Order Pharmacy delivery capabilities using DelivMeds app.

PPD, INC. (NasdaqGS:PPD) is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 23,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.

SCHRODINGER, INC. (NasdaqGS:SDGR) industry-leading computational platform to accelerate drug discovery and materials design is deployed by leading biopharmaceutical and industrial companies, academic institutions and government laboratories worldwide. Schrödinger is also applying its computational platform to a robust pipeline of drug discovery programs in collaboration with pharmaceutical companies and has co-founded leading biotech companies, including Nimbus Therapeutics. In addition, Schrödinger is using its platform to advance a pipeline of internal, wholly-owned drug discovery programs

Revolution Medicines, Inc. (NasdaqGS:RVMD) is a clinical-stage oncology company focused on developing novel targeted therapies to inhibit elusive high-value frontier cancer targets within notorious growth and survival pathways, with particular emphasis on RAS and mTOR signaling pathways. The company possesses sophisticated structure-based drug discovery capabilities built upon deep chemical biology and cancer pharmacology know-how and innovative, proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. The company’s pipeline includes RMC-4630, a clinical-stage drug candidate that is designed to selectively inhibit the activity of SHP2.  Additionally, the company is developing a broad portfolio of inhibitors of other key frontier oncology targets within the notorious RAS pathway, as well as the related mTOR signaling cascade.  These include inhibitors of multiple mutant RAS proteins and SOS1, as well as RMC-5552, a development candidate within the company’s 4EBP1/mTORC1 program currently in IND-enabling studies.

Mark A. Goldsmith CEO

New  stock added to Luxury Retail stocks directory  :

CASPER SLEEP INC. (NYSE:CSPR) is a global sleep company. The company has a full portfolio of obsessively engineered sleep products—including mattresses, pillows, bedding, and furniture—designed in-house by the company’s award-winning R&D team at Casper Labs in San Francisco. In addition to its global ecommerce business, Casper owns and operates 60 Sleep Shops across North America and its products are available at a growing list of retailers.

New stocks added to Sports stock directory :

ONEWATER MARINE INC. (NasdaqGM:ONEW) is one of the largest and fastest-growing premium recreational boat retailers in the United States. OneWater operates 63 stores throughout 11 different states, eight of which are in the top twenty states for marine retail expenditures. OneWater offers a broad range of products and services and has diversified revenue streams, which include the sale of new and pre-owned boats, parts and accessories, finance and insurance products, maintenance and repair services and ancillary services such as boat storage.

New stock added to Homebuilder/Real Estate Stock Directory

NEXPOINT REAL ESTATE FINANCE, INC. (NYSE:NREF) is a commercial real estate finance company that intends to elect to be treated as a real estate investment trust. NREF's strategy is to originate, structure and invest in first mortgage loans, mezzanine loans, preferred equity and alternative structured financings in commercial real estate properties, as well as multifamily commercial mortgage backed securities.

New  stocks added to Food/Beverage stocks directory and health wellness stocks

Muscle Maker, Inc. (NasdaqCM:GRIL) Founded in 1995 in Colonia, New Jersey, Muscle Maker Grill features high quality, great tasting food, freshly prepared with proprietary recipes. The menu, created with the guest’s health in mind, is lean and protein based. It features all-natural chicken, grass fed steak, lean turkey, whole wheat pasta, wraps, bowls and more. It also offers a wide selection of fruit smoothies in a variety of assorted flavors, protein shakes and supplements.

New stock added to China Stocks directory

HUIZE HOLDING LTD (NasdaqGM:HUIZ) is a leading independent online insurance product and service platform in China. Targeting the younger generation, we are dedicated to serving our insurance clients for their life-long insurance needs. Leveraging our online platform, we offer a wide variety of insurance products with a focus on long-term life and health insurance products, which are particularly suitable for our clients.

New stock added to crypto/blockchain stock directory  

Bitfarms Ltd. (TSXV:BITF.V) through its subsidiaries, engages in the mining of cryptocurrency coins and tokens. It owns and operates server farms that primarily support the validation and verification of transactions on the Bitcoin blockchain, earning cryptocurrency tokens for providing this service.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.

We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

Sign up to get Investorideas.com original branded content - podcasts and commentary in the hottest sectors

https://www.investorideas.com/Resources/Newsletter.asp

To sponsor a daily podcast for the month or to be an expert guest please contact us!

Contact Investorideas.com

800-665-0411